check_circleStudy Completed

Diagnostic Imaging, Heart Defects, Congenital

Bayer Identifier:

Trial_85236

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Dose finding study with SH U 454 as an echocardiographic contrast agent for clarification of congenital malformations involving the right heart in patients from 0 - 18 years

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

1 - 18 Years
  • -

  • -

Trial summary

Enrollment Goal
49
Trial Dates
August 1986 - December 1988
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Echovist (α-D-Galactose, BAY86-4872)
Accepts Healthy Volunteer
N/A

Trial design

Open, uncontrolled dose finding study with SH U 454 as an echocardiographic contrast agent for clarification of congenital malformations involving the right heart in patients from 0 - 18 years
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.